| Date Filed | Type | Description |
| 07/25/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/06/2020 |
SC 13D/A
| ARCH VENTURE FUND VI LP reports a 5.7% stake in VBI Vaccines, Inc. |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/23/2019 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on VBI VACCINES INC.|
Txns:
| Bought 10,000,000 shares
@ $0.5, valued at
$5M
|
|
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/29/2018 |
SC 13G
| MENORA MIVTACHIM HOLDINGS LTD. reports a 5.4% stake in VBI Vaccines, Inc. |
| 02/09/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/19/2017 |
4
| Baxter Jeff (CEO, President) has filed a Form 4 on VBI VACCINES INC. |
| 04/19/2017 |
3
| Baxter Jeff (President and CEO) has filed a Form 3 on VBI VACCINES INC. |
| 04/19/2017 |
4
| DeWilde Michel (Director) has filed a Form 4 on VBI VACCINES INC.|
Txns:
| Granted 12,500 options to buy
@ $3.79, valued at
$47.4k
|
|
| 04/19/2017 |
3
| DeWilde Michel (Director) has filed a Form 3 on VBI VACCINES INC. |
| 03/31/2017 |
SC 13D
| Opko Health, Inc. reports a 15% stake in VBI Vaccines, Inc. |
| 03/09/2017 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 21.5% stake in VBI VACCINES INC. |
| 03/09/2017 |
4/A
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on VBI VACCINES INC. |
| 02/10/2017 |
SC 13G/A
| Honig Barry C reports a 9.6% stake in , AND VBI Vaccines, Inc. |
| 02/10/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 12/09/2016 |
SC 13D
| VBI VACCINES INC. reports a 20.5% stake in VBI VACCINES INC. |
| 12/08/2016 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on VBI VACCINES INC. |
| 05/26/2016 |
SC 13G/A
| Honig Barry C reports a 9.3% stake in , AND VBI Vaccines, Inc. |
| 05/16/2016 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 05/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 05/12/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 05/09/2016 |
8-K
| Quarterly results |
| 05/09/2016 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits|
Docs:
|
"SciVac Therapeutics and VBI Vaccines Announce Completion of Merger Transaction ● SciVac Therapeutics changes its name to VBI Vaccines ● Combined company to begin trading on The NASDAQ Capital Market under the symbol “VBIV” ● Combined company is a biotechnology company with a licensed hepatitis B vaccine and a pipeline of novel technologies that seek to expand vaccine protection in large underserved markets CAMBRIDGE, MA – VBI Vaccines Inc., a Delaware corporation , and SciVac Therapeutics Inc., a British Columbia corporation , are pleased to announce the completion of their previously announced merger transaction, whereby SciVac acquired VBI. VBI survives the merger as a wholly owned subsidiary of SciVac. Upon completion of the merger, SciVac changed its name to VBI Vacci...",
"Additional Details Relating to the SciVac Therapeutics and VBI Vaccines Merger Transaction ● SciVac Therapeutics changed its name to VBI Vaccines ● On May 6, 2016, each share of VBI Vaccines common stock was converted into the right to receive 0.520208 common shares of post-merger VBI Vaccines ● On May 9, 2016, the combined entity began trading on The NASDAQ Capital Market under the symbol “VBIV” CAMBRIDGE, MA – VBI Vaccines Inc., a Delaware corporation , and SciVac Therapeutics Inc., a British Columbia corporation , are pleased to announce the completion of the previously announced merger transaction, whereby SciVac acquired VBI. VBI survives the merger as a wholly-owned subsidiary of SciVac. Listing Information SciVac changed its name to VBI Vaccines Inc. and the combin..." |
|
| 05/09/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 05/09/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 05/09/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 05/09/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 05/09/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 05/09/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 05/02/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 04/28/2016 |
8-K
| Form 8-K - Current report |
| 04/14/2016 |
8-K
| Form 8-K - Current report |
| 04/14/2016 |
425
| Form 425 - Prospectuses and communications, business combinations |
|